Palliative radiation for pelvic tumor symptoms
Part of Cancer, Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a type of radiation to help relieve symptoms like pain, bleeding, or other discomfort from tumors in the pelvic area. It is for people whose cancer has spread or cannot be cured, and who are not able to have stronger treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer that cannot be cured, either because it has spread or because of other health problems like age or medical conditions.
- Your cancer started in the digestive system, urinary tract, or female reproductive organs (like stomach, colon, bladder, ovary, or uterus).
- You have a tumor in the pelvic area causing symptoms like pain, bleeding, or problems with bowel, bladder, or vaginal function, and these symptoms are at least a 4 on a scale of 0 to 10.
- You are at least 18 years old and speak English or Norwegian.
- You can pause any cancer medications for one week before, during, and one week after radiation, and you are expected to live more than 12 weeks.
- If you are a woman who could become pregnant, you must have a negative pregnancy test and use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
This study looks at how a planned form of palliative radiation therapy treats certain solid cancers that have spread outside the brain to larger soft-tissue areas. It may help shrink tumors and relieve symptoms, but it also asks you to meet specific safety and treatment-timing rules.
This trial looks at giving radiation to shrink or control advanced cervical cancer to help with symptoms, especially pain. It is for people who are not good candidates for full curative treatment and are expected to have limited time, so the goal is comfort rather than cure.
This trial tests a higher dose of radiation to shrink large tumors and relieve pain in people with advanced cancer. It aims to improve quality of life by targeting up to three large tumors with a single treatment.
This trial studies a specific radiation schedule aimed at the pelvis (lower belly area) for uterine or cervical cancer. It looks at whether this “hypofractionated” approach can control cancer while limiting side effects, especially in patients whose disease has not spread to distant organs.
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
Hear when a new Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.